Jamie Clark
Stock Analyst at Rothschild & Co Redburn
(2.31)
# 3,157
Out of 4,707 analysts
15
Total ratings
75%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiated Coverage: Buy | $385 | $324.14 | +18.78% | 1 | Sep 8, 2026 | |
| GH Guardant Health | Initiated Coverage: Buy | $203 | $160.98 | +26.10% | 1 | Sep 8, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | $67 | $64.29 | +4.22% | 1 | Sep 8, 2026 | |
| ICLR ICON Public Limited Company | Downgraded: Hold | $236 → $100 | $158.34 | -36.84% | 3 | Feb 17, 2026 | |
| CERT Certara | Initiated Coverage: Buy | $10 | $7.74 | +29.20% | 1 | Nov 21, 2025 | |
| WST West Pharmaceutical Services | Initiated Coverage: Buy | $311 | $337.75 | -7.92% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgraded: Hold | $474 | $590.89 | n/a | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgraded: Buy | $188 → $182 | $280.76 | n/a | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiated Coverage: Buy | $276 | $324.86 | n/a | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiated Coverage: Buy | $195 | $235.50 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 650.00 | CHF 556.00 | n/a | 1 | Nov 27, 2024 |
Natera
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $385
Current: $324.14
Upside: +18.78%
Guardant Health
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $203
Current: $160.98
Upside: +26.10%
Tempus AI
Sep 8, 2026
Initiated Coverage: Hold
Price Target: $67
Current: $64.29
Upside: +4.22%
ICON Public Limited Company
Feb 17, 2026
Downgraded: Hold
Price Target: $236 → $100
Current: $158.34
Upside: -36.84%
Certara
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $7.74
Upside: +29.20%
West Pharmaceutical Services
Sep 15, 2025
Initiated Coverage: Buy
Price Target: $311
Current: $337.75
Upside: -7.92%
Medpace Holdings
Sep 3, 2025
Downgraded: Hold
Price Target: $474
Current: $590.89
Upside: n/a
Charles River Laboratories International
May 23, 2025
Upgraded: Buy
Price Target: $188 → $182
Current: $280.76
Upside: n/a
Labcorp Holdings
Apr 2, 2025
Initiated Coverage: Buy
Price Target: $276
Current: $324.86
Upside: n/a
Quest Diagnostics
Apr 2, 2025
Initiated Coverage: Buy
Price Target: $195
Current: $235.50
Upside: n/a
Nov 27, 2024
Initiated Coverage: Buy
Price Target: CHF 650.00
Current: CHF 556.00
Upside: n/a